Abstract #POS0296: real-world bDMARD dosing in axSpA and PsA: TNFi are used in approved dosing for most pts, but, non-TNFi-bDMARDs were often used in higher doses, corresponding to increased PsO dosing. #EULAR2021 @RheumNow https://t.co/7Br5UWtHJo https://t.co/UC4UYQpxml